The role of reactive oxygen intermediates in experimental coccidioidomycois in mice

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Margolis, David A ^a,d,e   Viriyakosol, Suganya ^a,b,c   Fierer, Joshua ^a,b,c,d   Kirkland, Theo N ^a,b,c,d  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Coccidioidomycosis; host response; oxidative burst

Indexed keywords

FUNGAL PROTEIN; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOLOGY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IN VITRO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; LUNG; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RESPIRATORY BURST; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; COCCIDIOIDES; CYTOCHEMISTRY; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROSCOPY; MORTALITY; MOUSE MUTANT; PATHOLOGY; SURVIVAL;

ANIMALIA; ASPERGILLUS FUMIGATUS; COCCIDIOIDES; COCCIDIOIDES IMMITIS; MUS; SPHERULES;

ANIMALS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SURVIVAL ANALYSIS;

EID: 79953779469     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-71     Document Type: Article

References (36)

1. Coccidioidomycosis: A reemerging infectious disease. TN Kirkland J Fierer, Emerg Infect Dis 1996 2 3 192 199 10.3201/eid0203.960305 8903229 (Pubitemid 126444986)
2. Racial factors in coccidioidomycosis: mortality experience in Arizona: a review of the literature. WM Johnson, Ariz Med 1982 39 1 18 24 7059284
3. Epidemiology of coccidioidomycosis. D Pappagianis, Current Topics in Medical Mycology MR McGinnis, Ed Springer-Verlag New York 1988 199 238
4. Coccidioidomycosis. TM Chiller JN Galgiani DA Stevens, Infect Dis Clin North Am 2003 17 1 41 57 10.1016/S0891-5520(02)00040-5 12751260 (Pubitemid 36514570)
5. Chemotaxigenic activity of extracts from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. JN Galgiani RA Isenberg DA Stevens, Infect Immun 1978 21 862 865 711340 (Pubitemid 9011183)
6. Potential role of human polymorphonuclear leukocytes in the early host response to Coccidioides immitis. JN Galgiani, Coccidioidomycosis Proceedings of the 4th International Conference National Foundation for Infectious Diseases Washington, DC, Einstein, H, Catanzaro, A, 1985 181 190
7. Killing of endospores but not arthroconidia by immunologically activated polymorphonuclear neutrophils. E Brummer L Beaman DA Stevens, Coccidioidomycosis Proceedings of the 4th International Conference National Foundation for Infectious Disease Washington, DC, Einstein, H, Catanzaro, A, 1985 201 213
8. Coccidioidomycosis: factors affecting the host-parasite interaction. DJ Drutz M Huppert, J Infect Dis 1983 147 3 372 390 10.1093/infdis/147.3.372 6300253 (Pubitemid 13163175)
9. Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. CL Frey DJ Drutz, J Infect Dis 1986 153 5 933 943 10.1093/infdis/153.5.933 3701107 (Pubitemid 16114871)
10. Some evidence for the development of a phagocytic response by polymorphonuclear leukocytes recovered from the venous blood of dogs inoculated with Coccidioides immitis or vaccinated with an irradiated spherule vaccine. TN Wegner RE Reed RJ Trautman CD Beavers, Am Rev Respir Dis 1972 105 845 849 5020634
11. Interaction of nonhuman primate peripheral blood leukocytes and Coccidioides immitis in vitro. L Beaman CA Holmberg, Infect Immun 1980 29 3 1200 1201 6776061 (Pubitemid 10009334)
12. Inhibition of different phases of Coccidioides immitis by human neutrophils or hydrogen peroxide. JN Galgiani, J Infect Dis 1986 153 2 217 222 10.1093/infdis/153.2.217 3944479 (Pubitemid 16156052)
13. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. TN Kirkland J Fierer, Infect Immun 1983 40 912 917 6852925
14. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. TN Kirkland F Finley KI Orsborn JN Galgiani, Infect Immun 1998 66 8 3519 3522 9673228 (Pubitemid 28347803)
15. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. LA Shubitz JJ Yu CY Hung TN Kirkland T Peng R Perrill J Simons J Xue RA Herr GT Cole,, et al. Vaccine 2006 24 5904 5911 10.1016/j.vaccine.2006.04.002 16759762 (Pubitemid 43947385)
16. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis. RA Herr CY Hung GT Cole, Infect Immun 2007 75 12 5777 5787 10.1128/IAI.00807-07 17875631 (Pubitemid 350207817)
17. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice. EJ Tarcha V Basrur CY Hung MJ Gardner GT Cole, Infect Immun 2006 74 1 516 527 10.1128/IAI.74.1.516- 527.2006 16369008 (Pubitemid 43023107)
18. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. TN Kirkland E Raz SK Datta, Vaccine 2006 24 495 500 10.1016/j.vaccine.2005.07.092 16181709 (Pubitemid 41832553)
19. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. JD Pollock DA Williams MAC Gifford LL Li X Du J Fisherman SH Orkin CM Doerschuk MC Dinauer, Nature 1995 9 202 209
20. High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression. M del Pilar Jimenez L Walls J Fierer, Infect Immun 2006 74 6 3387 3395 10.1128/IAI.01985-05 16714569 (Pubitemid 43794529)
21. Coccidioidomycosis: host response and vaccine development. RA Cox DM Magee, Clin Microbiol Rev 2004 17 4 804 839 10.1128/CMR.17.4.804-839.2004 15489350 (Pubitemid 39372519)
22. Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. TN Kirkland J Fierer, J Immunol 1985 135 548 552 3998472 (Pubitemid 15012424)
23. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. DM Magee RA Cox, Infect Immun 1995 63 3514 3519 7642285
24. Immunization of mice with viable Cocidioides immitis. D Pappagianis HB Levine CE Smith RJ Berman GS Kobayashi, J Immunol 1961 86 28 34 13732668
25. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. L Romani F Fallarino A DeLuca C Montagnoli C D'Angelo T Zelante C Vacca F Bistoni MC Fioretti U Grohmann,, et al. Nature 2008 451 211 216 10.1038/nature06471 18185592
26. NADPH oxidase limits innate immune responses in the lungs in mice. BH Segal W Han JJ Bushey M Joo Z Bhatti J Feminella CG Dennis RR Vethanayagam FE Yull M Capitano,, et al. PLoS One 2010 5 3 9631 10.1371/journal.pone.0009631 20300512
27. phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate. R Rajakariar J Newson EK Jackson P Sawmynaden A Smith F Rahman MM Yaqoob DW Gilroy, J Immunol 2009 182 3262 3269 10.4049/jimmunol.0801739 19234224
28. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. KA Zarember JA Sugui YC Chang KJ Kwon-Chung JI Gallin, J Immunol 2007 178 6367 6373 17475866 (Pubitemid 46717421)
29. Role of NADPH oxidase in host defense against aspergillosis. MJ Grimm RR Vethanayagam NG Almyroudis D Lewandowski N Rall TS Blackwell BH Segal, Med Mycol 2011 Suppl 1 114 119 20507264
30. Virulence of catlase-deficinet Aspergillus nidulans in p47phox-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. YC Chang BH Segal SM Holland GF Miller KJ Kwon-Chung, J Clin Inest 1998 101 1843 1850 10.1172/JCI2301 (Pubitemid 28226102)
31. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. EP Reeves H Lu HL Jacobs CG Messina S Bolsover G Gabella EO Potma A Warley J Roes AW Segal, Nature 2002 416 6878 291 297 10.1038/416291a 11907569 (Pubitemid 34260237)
32. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. C D'Angelo A De Luca T Zelante P Bonifazi S Moretti G Giovannini RG Iannitti S Zagarella S Bozza S Campo,, et al. J Immunol 2009 183 7 4609 4618 19734205
33. Impaired host defense against Sporothrix schenkii in mice with chronic granulomatous disease. H Kajiwara M Saito S Ohga T Uenotsuchi SI Yoshida, Infect Immun 2004 72 9 5073 5079 10.1128/IAI.72.9.5073-5079.2004 15322000 (Pubitemid 39223391)
34. Chronic granulomatous disease. SM Holland, Clin Rev Allergy Immunol 2010 38 3 10 10.1007/s12016-009-8136-z 19504359
35. High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression. M del Pilar Jimenez L Walls J Fierer, Infect Immun 2006 74 6 3387 3395 10.1128/IAI.01985-05 16714569 (Pubitemid 43794529)
36. Coccidioides releases a soluble factor that suppresses nitric oxide production by murine primary macrophages. A Gonzalez CY Hung GT Cole, Microb Pathog 2011 20 2 100 108 10.1016/j.micpath.2010.11.006